![Management of androgen-ablation refractory prostate cancer. Role](http://s1.studyres.com/store/data/000637894_1-4cdbd28e65e533deb9762003b7c04e63-300x300.png)
Management of androgen-ablation refractory prostate cancer. Role
... treat patients with AAR cancers and they include even more effective androgen blockade by for example glucocorticoids or ketoconazole. Some of the tumours differentiate into neuroendocrine tumours and become completely independent of androgen stimulation. It is believed that these tumours over-expre ...
... treat patients with AAR cancers and they include even more effective androgen blockade by for example glucocorticoids or ketoconazole. Some of the tumours differentiate into neuroendocrine tumours and become completely independent of androgen stimulation. It is believed that these tumours over-expre ...
Noradrenergic Transmission
... Prazosin (short half-life) Doxazosin, terazosin (long half life ) 1–antagonists cause : Vasodilatation due to relaxation of arterial and venous smooth muscles Fall in arterial pressure with less tachycardia than with non-selective blockers ...
... Prazosin (short half-life) Doxazosin, terazosin (long half life ) 1–antagonists cause : Vasodilatation due to relaxation of arterial and venous smooth muscles Fall in arterial pressure with less tachycardia than with non-selective blockers ...
essa pharma provides clinical study update and announces
... the treatment of castration resistant prostate cancer (“CRPC”) in patients whose disease is progressing despite treatment with current therapies. ESSA believes that its product candidate, EPI-506, can significantly expand the interval of time in which patients suffering from CRPC can benefit from ho ...
... the treatment of castration resistant prostate cancer (“CRPC”) in patients whose disease is progressing despite treatment with current therapies. ESSA believes that its product candidate, EPI-506, can significantly expand the interval of time in which patients suffering from CRPC can benefit from ho ...
No Slide Title
... structure. The output of most screens Progressible hit: a representative of a compound series with activity via acceptable mechanism of action and some limited structure-activity relationship information ...
... structure. The output of most screens Progressible hit: a representative of a compound series with activity via acceptable mechanism of action and some limited structure-activity relationship information ...
Advanced Medicinal Chemistry
... A receptor is often the first step in a long intracellular signalling cascade leading to physiological effects G-Protein Coupled, Seven-Transmembrane Spanning Receptors comprise the majority of known examples ...
... A receptor is often the first step in a long intracellular signalling cascade leading to physiological effects G-Protein Coupled, Seven-Transmembrane Spanning Receptors comprise the majority of known examples ...
Advanced Medicinal Chemistry
... A receptor is often the first step in a long intracellular signalling cascade leading to physiological effects G-Protein Coupled, Seven-Transmembrane Spanning Receptors comprise the majority of known examples ...
... A receptor is often the first step in a long intracellular signalling cascade leading to physiological effects G-Protein Coupled, Seven-Transmembrane Spanning Receptors comprise the majority of known examples ...
Androgen deprivation therapy - managing side effects
... to androgen activity. It is often associated with breast pain and can lead to irreversible fibrosis when present for at least 1 year.29 The incidence has been shown to vary with the type of ADT, ranging from 1–16% with LHRH agonists to 79% with nonsteroidal anti-androgen therapy.30 Treatment options ...
... to androgen activity. It is often associated with breast pain and can lead to irreversible fibrosis when present for at least 1 year.29 The incidence has been shown to vary with the type of ADT, ranging from 1–16% with LHRH agonists to 79% with nonsteroidal anti-androgen therapy.30 Treatment options ...
Answers
... secretion from parietal cells. Lansoprazole is a proton pump (K+/H+ ATPase) inhibitor which blocks secretion of acid from parietal cells. Lansoprazole is more effective since it blocks stomach acid secretion directly. Ranitidine only blocks histamine-induced upregulation of stomach acid production, ...
... secretion from parietal cells. Lansoprazole is a proton pump (K+/H+ ATPase) inhibitor which blocks secretion of acid from parietal cells. Lansoprazole is more effective since it blocks stomach acid secretion directly. Ranitidine only blocks histamine-induced upregulation of stomach acid production, ...
2016 department of medicine research day
... proportion of ERα-positive BCs exhibit de novo or acquired resistance to current endocrine therapies due to ligand-dependent or –independent mechanisms. Another class of ERα antagonist- termed selective estrogen receptor downregulators (SERDs)- is represented by fulvestrant, a drug whose mechanism o ...
... proportion of ERα-positive BCs exhibit de novo or acquired resistance to current endocrine therapies due to ligand-dependent or –independent mechanisms. Another class of ERα antagonist- termed selective estrogen receptor downregulators (SERDs)- is represented by fulvestrant, a drug whose mechanism o ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Prostate Cancer Facts
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Cancer Prevention
... Patients in good health who are younger than 70 years old are usually offered surgery as treatment for prostate cancer. Impotence and urine leakage the bladder or stool from the rectum may occur in men treated with surgery. In some cases, doctors can use a technique known as nerve-sparing surgery. T ...
... Patients in good health who are younger than 70 years old are usually offered surgery as treatment for prostate cancer. Impotence and urine leakage the bladder or stool from the rectum may occur in men treated with surgery. In some cases, doctors can use a technique known as nerve-sparing surgery. T ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
Cancer Prevention
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
... Hormone therapy Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances produced by glands in the body and circulated in the bloodstream. The presence of some hormones can cause certain cancers to grow. If tests ...
prostate cancer - National University Cancer Institute, Singapore
... A procedure called radical prostectomy may be recommended if the tumour is localised at the prostate. It involves the complete removal of the prostate and also often includes the pelvic lymph nodes. This procedure is commonly used to treat early stages of prostate cancer. Some possible side effects ...
... A procedure called radical prostectomy may be recommended if the tumour is localised at the prostate. It involves the complete removal of the prostate and also often includes the pelvic lymph nodes. This procedure is commonly used to treat early stages of prostate cancer. Some possible side effects ...
Losartar is an angiotensin II receptor antagonist drug used mainly to
... Losartar is a selective, competitive Angiotensin II receptor type 1 (AT1) receptor antagonist, reducing the end organ responses to angiotensin II. Losartar administration results in a decrease in total peripheral resistance (afterload) and cardiac venous return (preload) All of the physiological eff ...
... Losartar is a selective, competitive Angiotensin II receptor type 1 (AT1) receptor antagonist, reducing the end organ responses to angiotensin II. Losartar administration results in a decrease in total peripheral resistance (afterload) and cardiac venous return (preload) All of the physiological eff ...
ascoanswers
... likely to return, hormone therapy may be given before surgery or radiation therapy may be given after surgery. Several months of hormone therapy may also be combined with radiation therapy. Hormone therapy, radiation therapy, and chemotherapy are the main treatment options for men with metastatic pr ...
... likely to return, hormone therapy may be given before surgery or radiation therapy may be given after surgery. Several months of hormone therapy may also be combined with radiation therapy. Hormone therapy, radiation therapy, and chemotherapy are the main treatment options for men with metastatic pr ...
Slide ()
... shifted to the right. Maximal responsiveness is preserved, however, because the remaining available receptors are still in excess of the number required. In curve C, produced after treatment with a larger concentration of antagonist, the available receptors are no longer “spare”; instead, they are j ...
... shifted to the right. Maximal responsiveness is preserved, however, because the remaining available receptors are still in excess of the number required. In curve C, produced after treatment with a larger concentration of antagonist, the available receptors are no longer “spare”; instead, they are j ...
The Effect of 3 Years of Raloxifene on Vertebral and Non
... • RCT of watchful waiting vs. surgery in 695 men with local dz (Holmberg, 2002) – 75% had palpable dz, 10% detected from PSA – Mean age 64, 6.2 years follow up ...
... • RCT of watchful waiting vs. surgery in 695 men with local dz (Holmberg, 2002) – 75% had palpable dz, 10% detected from PSA – Mean age 64, 6.2 years follow up ...
- SlideBoom
... (PDGFRs), resulting in inhibition of ligandindependent leukemic cell proliferation and apoptosis. ...
... (PDGFRs), resulting in inhibition of ligandindependent leukemic cell proliferation and apoptosis. ...
Discovery and development of antiandrogens
![](https://commons.wikimedia.org/wiki/Special:FilePath/Androgen_receptor.png?width=300)
In the 1960s, the first antiandrogen, or androgen antagonist, was discovered. Antiandrogens antagonise the androgen receptor (AR) and thereby block the biological effects of testosterone and dihydrotestosterone (DHT). Antiandrogens are important for men with hormonally responsive diseases like prostate cancer, benign prostatic hyperplasia (BHP), acne, seborrhea, hirsutism and androgen alopecia. Antiandrogens are mainly used for the treatment of prostate diseases. Research from 2010 suggests that ARs could be linked to the disease progression of triple-negative breast cancer and that antiandrogens can potentially be used to treat it.As of 2010 antiandrogens are small molecules and can be either steroidal or nonsteroidal depending on ligand chemistry. Steroidal antiandrogens share a similar steroid structure, while nonsteroidal antiandrogens may have structurally distinctive pharmacophores. Only a limited number of compounds are available for clinical use despite the fact that a very large variety of antiandrogen compounds have been discovered and researched.